Theriva Biologics, Inc.TOVXNYSE
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+52.1%
5Y CAGR+10.3%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+52.1%/yr
Annual compound
5Y CAGR
+10.3%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.08 | +51.3% |
| 2023 | 0.05 | +76.1% |
| 2022 | 0.03 | +32.0% |
| 2021 | 0.02 | -60.4% |
| 2020 | 0.06 | +17.2% |
| 2019 | 0.05 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |
| 2015 | 0.00 | - |